Marshall Wace’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.9K | Buy |
+25,564
| New | +$40.9K | ﹤0.01% | 2460 |
|
2022
Q2 | – | Sell |
-2,014
| Closed | -$71K | – | 3031 |
|
2022
Q1 | $71K | Sell |
2,014
-5,664
| -74% | -$200K | ﹤0.01% | 2497 |
|
2021
Q4 | $209K | Buy |
+7,678
| New | +$209K | ﹤0.01% | 2465 |
|
2021
Q2 | – | Sell |
-4,041
| Closed | -$182K | – | 2422 |
|
2021
Q1 | $182K | Buy |
+4,041
| New | +$182K | ﹤0.01% | 1956 |
|
2017
Q1 | – | Sell |
-1,636
| Closed | -$788K | – | 626 |
|
2016
Q4 | $788K | Buy |
1,636
+72
| +5% | +$34.7K | 0.01% | 785 |
|
2016
Q3 | $1.06M | Hold |
1,564
| – | – | 0.01% | 706 |
|
2016
Q2 | $851K | Buy |
+1,564
| New | +$851K | 0.01% | 732 |
|